New formulation helps RNA vaccines withstand high temperatures
MIT researchers have developed a new way to stabilize RNA vaccines so they can survive higher temperatures, making them easier to distribute. The method uses an AI algorithm to improve the lipid nanoparticles that deliver the vaccines. Tests showed the vaccines remained effective even after being stored at room temperature for a year or near 100 degrees Fahrenheit for two months.
MIT engineers created a new formulation for RNA vaccines that makes them more heat-resistant, using an AI algorithm to improve the delivery system. This allows the vaccines to stay stable at higher temperatures without losing effectiveness.
This development could make RNA vaccines easier to distribute globally, especially in areas without access to cold storage, which is crucial for reaching more people with life-saving treatments.
The innovation shows how technology and science can solve real-world challenges, offering a practical solution that could improve public health and expand access to medical treatments.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.